News8 months ago
Loss of S$0.001 per share (compared to loss of S$0.001 in 1Q 2023)
Biolidics (Catalyst: 8YY) Results for the first quarter of 2024 Main financial results Revenue: S$137.0 thousand (down 88% compared to 1Q 2023). Net loss: S$760.0 thousand...
